Yet granting an exclusive licence on a university-owned patent deters follow-on innovations. Firms must now negotiate–and pay for–a licence before entering a market to access proprietary information that would previously have been available in publications.28 Instead of encouraging better technology transfer–for example, of human stem cell patents held by the University of Wisconsin–the system has delayed technology diffusion.29
